📰 John Menditto News
Page 2 - John Menditto News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from John Menditto. Real-time updates on events, politics, business and more.
August 7, 2023
BASKING RIDGE, N.J., Aug. 07, 2023 -- Lisata Therapeutics, Inc. , a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other...
August 7, 2023
07.08.2023 - BASKING RIDGE, N.J., Aug. 07, 2023 (GLOBE NEWSWIRE) - Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and ...
July 11, 2023
Lasker Prize winning researcher and serial entrepreneur will remain an advisor to the CompanyBASKING RIDGE, N.J., July 11, 2023 -- Lisata Therapeutics, Inc. , a clinical-stage pharmaceutical...
June 12, 2023
BASKING RIDGE, N.J., June 12, 2023 -- Lisata Therapeutics, Inc. , a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other... | June 12, 2023
May 24, 2023
Target enrollment increased to 155 subjects with the addition of a cohort testing a second dose of LSTA1 Results to be used to explore possible conditional approvals globally Futility analysis... | May 24, 2023
May 2, 2023
BASKING RIDGE, N.J., May 02, 2023 -- Lisata Therapeutics, Inc. , a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other... | May 2, 2023
April 18, 2023
The iLSTA Trial is the first study combining LSTA1 with standard-of-care chemotherapy and immunotherapy WARPNINE to provide funding and local trial management BASKING RIDGE, N.J. and... | April 18, 2023
November 13, 2022
Lisata Therapeutics, Inc. (NASDAQ:NASDAQ:LSTA) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants John Menditto - VP, IR and Corporate Communications Dave...
August 5, 2022
Caladrius Biosciences, Inc. (NASDAQ:NASDAQ:CLBS) Q2 2022 Results Conference Call August 04, 2022 4:30 PM ET Company Participants John Menditto - VP, IR & Corporate Communications David...
July 6, 2022
BASKING RIDGE, N.J. and SAN DIEGO, July 06, 2022 -- Caladrius Biosciences, Inc. , a clinical-stage biopharmaceutical company developing innovative therapies designed to treat or reverse... | July 6, 2022